By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Harrison.ai trims Australian staff to fund US AI radiology push
    By
    msadmin
    September 9, 2026
    Naver taps its EMR startup’s co-CEOs to lead new health unit
    By
    msadmin
    September 9, 2026
    Sanofi India will mentor and may fund AI heart startup Tricog
    By
    msadmin
    September 9, 2026
    Samsung Medison’s HERA Z10 AI ultrasound halves prenatal scan time
    By
    msadmin
    September 9, 2026
    AI lung CT analysis catches taladegib effect in a 12-week IPF trial
    By
    msadmin
    September 9, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
    Teladoc puts 100 percent of fees at risk with new AI-powered platform
    By
    msadmin
    July 27, 2026
    Johns Hopkins finds frontier AI agents fail most complex health tasks
    By
    msadmin
    July 27, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
ArticlesSpotlight

EY Expert Urges Healthcare Leaders to Double Down on AI Amid Economic Uncertainty

Despite financial headwinds, AI strategies can help healthcare systems navigate challenges and improve outcomes if approached with focus, scale, and value in mind.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Published: July 11, 2025
Share
3 Min Read
SHARE

As first reported by Healthcare IT News, the uncertain financial outlook for U.S. healthcare—marked by looming Medicaid cuts and the threat of rural hospital closures—is prompting many leaders to pause or reevaluate strategic investments. Yet, according to Ernst & Young’s Health AI and Data Leader Sezin Palmer, now is not the time to pull back on AI. Instead, it’s the time to scrutinize technology choices and vendors to ensure they support resilient, cost-effective care strategies that can weather the storm.

Sezin Palmer. Source: ey.com.

Palmer, a leader in applying advanced analytics and artificial intelligence to healthcare, believes AI can play a central role in managing both risk and resources. On a recent HIMSSCast, she emphasized that health systems must be deliberate—prioritizing value-driven and scalable implementations. Her guidance includes leveraging existing data and tools, focusing on high-impact use cases, and working closely with consultants and vendors to extract the most benefit without overspending or overcomplicating deployments.

She also stressed the importance of retooling internal talent to work alongside AI tools and making the most of available resources before investing in new ones. Rather than chasing the latest AI trend, Palmer recommends building strategies that align with clinical and financial priorities. Her advice is to evaluate AI initiatives by how well they support care quality, efficiency, and long-term cost reduction, especially during turbulent economic times.

A focused approach to sustainable innovation

Palmer’s message to healthcare executives is clear: AI, when applied wisely, is not a luxury—it’s a necessity. The key is to be selective, pragmatic, and patient-focused, ensuring that every AI decision contributes meaningfully to both the bottom line and better care delivery.

As healthcare organizations brace for financial uncertainty, leaders like Sezin Palmer advocate for smarter—not smaller—AI investments. By focusing on scalable value, thoughtful vendor partnerships, and strategic talent use, hospitals and health systems can leverage AI as a stabilizing force. In times of volatility, artificial intelligence isn’t just a tech upgrade—it’s a tool for survival and transformation.

VIA:Healthcare IT News
Share This Article
Facebook Copy Link Print
Yu Chi Huang
ByYu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.

You Might Also Like

ArticlesNews & Alerts

Bipartisan senators probe Medicare Advantage AI care denials

By
msadmin
July 17, 2026
Articles

AI Partnerships and Imaging Advances Reshape Clinical Workflows in Health Systems

By
msadmin
June 17, 2026
Articles

AI tops global healthcare IT investment priorities, KLAS finds

By
msadmin
July 22, 2026
ArticlesNews & Alerts

AI-powered biosimulation shakes up animal drug testing

By
msadmin
July 17, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal